Aldea raises $24M for drug that targets severe drunkenness
This one’s a hair better than, ah, the hair of the dog: Aldea Pharmaceuticals’ drug for acute alcohol intoxication is advancing into clinical trials, thanks to a sizable new round of funding. The new drug’s meant to be intravenously administered to emergency room patients with alcohol poisoning. The company just closed out a $24 million Series […]